Ratifi English Iniciar sesión
Ratifi

Proyectos federales de Congress.gov. Proyectos estatales de Open States.

HB 144Sesión 34

Qué cambió entre versiones

10 párrafos cambiaron+418 palabras agregadas−474 eliminadas

El texto resaltado se agregó en la versión más reciente. El texto tachado se eliminó.

Home

51 párrafos sin cambios

Current Members

By Session

Alphabetical

Current Members

By Session

Alphabetical

All Introduced

Actions by Date

Awaiting Actions

Bills sent to Conf Committee

Bills in Committee

Governor's Vetoes

Passed Legislation

Prefile Bill Summary

Requestor Summary

Statistics

Sponsor Summary

Subject Summary

Constitution

Constitutional Convention Files

Statutes

Executive Orders - Current

Executive Orders - Historical

Administrative Code

Journals

Session Laws & Resolves 2025

Session Laws & Resolves 2026

1981 - Previous Year Session Law

1983 - Previous Year Legislative Resolves

Statute Information Retrieval System

Bill Tracking Management Facility

Past Legislatures (Archives)

Hearing Schedule

Standing Committees

Finance Committees

Special Committees

Joint Committees

Conference Committees

Other Committees

Minutes

Publications

Get Started

Information Offices

Legislative Affairs

Legislative Agencies

Legislative Branch

Executive Branch

Judicial Branch

Alaska Delegation

Home

Bill & Laws

Bills

HBCSHB 144(HSS) Detail

FullText

HBCSHB 144(HSS): "An Act relating to prior authorization requests for medical care covered by a health care insurer; relating to a prior authorization application programming interface; relating to step therapy; and providing for an effective date."

00 CS FOR HOUSE BILL NO. 144(HSS) 01"An Act relating to prior authorization requests for medical care covered by a health 02 care insurer; relating to a prior authorization application programming interface; 03 relating to step therapy; and providing for an effective date." 04 BE IT ENACTED BY THE LEGISLATURE OF THE STATE OF ALASKA: 05 * Section 1. AS 21.07.080 is amended to read: 06 Sec. 21.07.080. Religious nonmedical providers. AS 21.07.005 - 21.07.090 07 [THIS CHAPTER] may not be construed to 08 (1) restrict or limit the right of a health care insurer to include services 09 provided by a religious nonmedical provider as medical care services covered by the 10 health care insurance policy; 11 (2) require a health care insurer, when determining coverage for 12 services provided by a religious nonmedical provider, to 13 (A) apply medically based eligibility standards; 14 (B) use health care providers to determine access by a covered

01 person; 02 (C) use health care providers in making a decision on an 03 internal or external appeal; or 04 (D) require a covered person to be examined by a health care 05 provider as a condition of coverage; or 06 (3) require a health care insurance policy to exclude coverage for 07 services provided by a religious nonmedical provider because the religious 08 nonmedical provider is not providing medical or other data required from a health care 09 provider if the medical or other data is inconsistent with the religious nonmedical 10 treatment or nursing care being provided. 11 * Sec. 2. AS 21.07 is amended by adding new sections to read: 12 Article 2. Prior Authorizations. 13 Sec. 21.07.100. Prior authorization requests. (a) A health care insurer 14 offering a health plan issued or renewed on or after January 1, 2027, shall designate a 15 prior authorization process that complies with the standards for prior authorizations for 16 medical care and prescription drugs in AS 21.07.100 - 21.07.180. The process must be 17 reasonable and efficient and minimize administrative burdens on health care providers 18 and facilities. 19 (b) If a health care provider submits a prior authorization request that contains 20 the information necessary to make a determination, a health care insurer shall make a 21 determination and notify the provider of the decision within 22 (1) 72 hours after receiving a standard request submitted by a method 23 other than facsimile; 24 (2) 72 hours, excluding weekends, after receiving a standard request 25 submitted by facsimile; or 26 (3) 24 hours after receiving an expedited request. 27 (c) If a health care provider submits a prior authorization request that does not 28 contain the information necessary to make a determination, the health care insurer 29 shall request specific additional information from the covered person's health care 30 provider within 31 (1) one calendar day after receiving an expedited request; or

01 (2) three calendar days after receiving a standard request. 02 (d) If a health care insurer determines that the information provided by a 03 health care provider is not sufficient to make a determination under (b) of this section, 04 the health care insurer may request additional information. The health care insurer 05 may establish a due date of not less than five nor more than 14 working days after 06 receiving the prior authorization request by which the additional information must be 07 submitted. The health care insurer must notify the health care provider and covered 08 person of the due date along with the request for additional information and specify 09 the additional information needed to complete the request. 10 (e) A health care insurer that receives a prior authorization request from a 11 health care provider shall provide to the health care provider confirmation of receipt 12 that shows the date and time the request was received by the health care insurer. 13 (f) A prior authorization request submitted under this section is considered 14 approved if the health care insurer fails to provide a written denial, approval, or 15 request for additional information within the time specified under this section. 16 Sec. 21.07.110. Prior authorization standards. (a) A health care insurer shall 17 make its most current prior authorization standards available to a covered person and 18 health care provider on the health care insurer's Internet website, including 19 information or documentation to be submitted by the covered person or health care 20 provider or facility. If the health care insurer provides a portal, the insurer shall also 21 make the prior authorization standards available on the portal. A health care insurer 22 shall describe the standards in detailed, easily understood language. 23 (b) A health care insurer's prior authorization standards must include prior 24 authorization requirements used by the insurer and by the insurer's utilization review 25 organizations. The prior authorization requirements must be based on peer-reviewed, 26 evidence-based clinical review criteria and be consistently applied by all sources, 27 including utilization review organizations, to avoid discrepancies or conflicts. The 28 health care insurer shall evaluate and, if necessary, update the clinical review criteria 29 at least annually. 30 (c) If the prior authorization standards published by the health care insurer 31 differ from those published by the health care insurer's utilization review organization,

01 the health care insurer shall use the prior authorization standard most favorable to the 02 covered person. 03 (d) A health care insurer shall indicate on its Internet website, for each service 04 subject to prior authorization, 05 (1) whether a standardized electronic prior authorization request 06 transaction process is available; and 07 (2) the date the prior authorization requirement 08 (A) became effective for a policy issued or delivered in this 09 state; and 10 (B) was first listed on the health care insurer's Internet website. 11 (e) If the prior authorization requirement is terminated, a health care insurer 12 shall indicate on its Internet website the date the prior authorization requirement was 13 removed for a policy issued or delivered in this state. 14 Sec. 21.07.120. Peer review of prior authorization request. (a) A health care 1512 insurer shall establish a process for a health care provider to request a clinical peer 1613 review of a prior authorization request. 1714 (b) A peer reviewer must have relevant clinical expertise in the specialty area 1815 or be of an equivalent specialty as the health care provider submitting the prior 1916 authorization request. A peer reviewer shall attest, in writing or electronically, that the 2017 reviewer has personally reviewed and considered all medical notes and relevant 2118 clinical information submitted as part of the prior authorization request. 2219 (c) A health care insurer shall provide to a health care provider at the 2320 provider's request the qualifications of a peer reviewer issuing an adverse decision on 2421 a prior authorization request, including the specialty and relevant board certifications 2522 of the peer reviewer. 2623 Sec. 21.07.130. Period of validity of prior authorization. (a) A prior 2724 authorization for a chronic condition is valid for a period of not less than 12 months 2825 while the covered person remains covered by the health care policy. If the treatment 2926 plan for a chronic condition is unchanged and the covered person's health care 3027 provider submits to the health care insurer certification of compliance with the current 3128 treatment plan, the health care insurer shall automatically renew the prior 29 authorization approval for the chronic condition for an additional 12-month period. 30 (b) Except for a prior authorization for a chronic condition subject to (a) of 31 this section, a prior authorization is valid for a period of 90 calendar days or a duration

01 authorization approval for the chronic condition for an additional 12-month period. 02 (b) Except for a prior authorization for a chronic condition subject to (a) of 03 this section, a prior authorization is valid for a period of 90 calendar days or a duration 04 that01that is clinically appropriate, whichever is longer. If a health care insurer intends to 0502 implement a new prior authorization requirement or restriction, or amend an existing 0603 requirement or restriction, the health care insurer shall provide a participating health 0704 care provider written notice of the new or amended requirement or restriction not less 0805 than 60 days before the requirement or restriction is implemented. The health care 0906 insurer shall post notice on the health care insurer's public facing, accessible Internet 1007 website not less than 60 days before implementation of the requirement or restriction. 1108 If a health care provider agrees in advance to receive notices electronically, the written 1209 notice may be provided in an electronic format. The health care insurer may not 1310 implement a new or amended requirement until the Internet websites of both the health 1411 care insurer and the utilization review organization have been updated to reflect the 1512 new or amended requirement or restriction. 1613 Sec. 21.07.140. Adverse determinations. If a health care insurer makes an 1714 adverse prior authorization determination, the health care insurer shall notify the 1815 covered person and the covered person's health care provider and provide each 1916 (1) a clear explanation of the reasons for the adverse determination, 2017 including the specific evidence-based reasons and criteria used to make the 2118 determination and a description of any specific missing or insufficient information that 2219 contributed to the adverse determination; 2320 (2) a statement of the covered person's right to appeal the adverse 2421 determination; 2522 (3) instructions on how to file an appeal, including a clear explanation 2623 of the appeals process, appeal timeline, and the direct telephone number and electronic 2724 and physical mailing addresses for appeals. 2825 Sec. 21.07.150. Prior authorization application programming interface. A 2926 health care insurer shall maintain a prior authorization application programming 3027 interface that automates the process for health care providers to determine whether a 3128 prior authorization is required for medical care, identify prior authorization 29 information and documentation requirements, and facilitate the exchange of prior 30 authorization requests and determinations from its electronic health records or practice 31 management system. The application programming interface must be consistent with

01information and documentation requirements, and facilitate the exchange of prior 02 authorization requests and determinations from its electronic health records or practice 03 management system. The application programming interface must be consistent with 04 the01the technical standards and implementation dates established in the Centers for 0502 Medicare and Medicaid Services rules on interoperability and patient access. The 0603 application programming interface must support the exchange of prior authorization 0704 requests and determinations for medical care and prescription drugs, including 0805 information on covered alternative prescription drugs. The application programming 0906 interface must indicate that a prior authorization denial, an authorization of medical 1007 care less intensive than the medical care included in the original request, or an 1108 authorization of a prescription drug other than the one included in the original prior 1209 authorization request is an adverse benefit determination and is subject to the health 1310 care insurer's grievance and appeal process under AS 21.07.005. 1411 Sec. 21.07.160. Step therapy restrictions and exceptions. (a) A health care 1512 insurer that provides coverage under a health care insurance policy for the treatment of 1613 Stage 4 advanced metastatic cancer may not limit or exclude coverage under the health 1714 benefit plan for a drug that is approved by the United States Food and Drug 1815 Administration and that is on the insurer's prescription drug formulary by mandating 1916 that a covered person with Stage 4 advanced metastatic cancer undergo step therapy if 2017 the use of the approved drug is an approved indication by the United States Food and 2118 Drug Administration or on the National Comprehensive Cancer Network Drugs and 2219 Biologics Compendium as an indication for the treatment of Stage 4 advanced 2320 metastatic cancer consistent with Category 1 or Category 2A of evidence and 2421 consensus or peer-reviewed medical literature. 2522 (b) If coverage of a prescription drug for the treatment of any medical 2623 condition is restricted by a health care insurer or utilization review organization 2724 because of a step therapy protocol, the health care insurer or utilization review 2825 organization must provide a covered person and the covered person's health care 2926 provider with access to a clear, convenient, and readily accessible process for 3027 requesting an exception to application of the step therapy protocol. A health care 3128 insurer or utilization review organization may use its existing medical exceptions 29 process to satisfy this requirement. The health care insurer or utilization review 30 organization shall disclose the process to the covered person and the covered person's 31 health care provider, along with the information needed to process the request, and

01process to satisfy this requirement. The health care insurer or utilization review 02 organization shall disclose the process to the covered person and the covered person's 03 health care provider, along with the information needed to process the request, and 0401 make the process available on the health care insurer's Internet website for the plan. 0502 (c) A health care insurer or utilization review organization shall grant a step 0603 therapy exception under this section if the covered person has tried the prescription 0704 drugs required under the step therapy protocol while under a current or previous health 0805 care insurance policy or health benefit plan, including a health care insurance policy or 0906 health benefit plan offered by a different insurer or payor, and the prescription drugs 1007 were discontinued because of lack of efficacy or effectiveness, diminished effect, or 1108 an adverse event or if the covered person's health care provider attests that coverage of 1209 the prescribed prescription drug is necessary to save the life of the covered person. 1310 Use of drug samples from a pharmacy may not be considered trial and failure of a 1411 preferred prescription drug required under a step therapy protocol. 1512 (d) The health care insurer or utilization review organization may request 1613 relevant information from the covered person or the covered person's health care 1714 provider to support a step therapy exception request made under this section. Upon 1815 granting a step therapy exception request, the health care insurer or utilization review 1916 organization shall authorize dispensation of and coverage for the prescription drug 2017 prescribed by the covered person's health care provider if the drug is a covered drug 2118 under the health care insurance policy. 2219 (e) This section may not be construed to prevent a 2320 (1) health care insurer or utilization review organization from requiring 2421 a covered person to try a generic equivalent or other brand name drug before 2522 providing coverage for the requested prescription drug; or 2623 (2) health care provider from prescribing a prescription drug that the 2724 provider determines is medically appropriate. 2825 Sec. 21.07.170. Annual report. A health care insurer shall submit an annual 2926 report to the director, on a form prescribed by the director, detailing compliance with 3027 the requirements of AS 21.07.100 - 21.07.180. The report must include 3128 (1) documentation of compliance with prior authorization response 29 times and other prior authorization requirements; 30 (2) evidence of transparency and accessibility of prior authorization 31 requirements and clinical review criteria;

01 times and other prior authorization requirements; 02 (2) evidence of transparency and accessibility of prior authorization 03 requirements and clinical review criteria; 04 (3) information on the implementation and functioning of any prior 0502 authorization application programming interfaces; 0603 (4) records of any prior authorization denials and the associated 0704 appeals process, including the number of prior authorization approvals and denials, 0805 reasons for denials, number of appeals, appeal outcomes, and, for the insurer's 20 most 0906 frequently billed codes, average approval times by diagnosis code and demographic 1007 information of the covered persons; 1108 (5) any other information required by the director. 1209 Sec. 21.07.180. Compliance and enforcement. (a) The director shall monitor 1310 compliance with the provisions of AS 21.07.100 - 21.07.180. 1411 (b) The director shall conduct examinations of health care insurers in 1512 accordance with AS 21.06.120 - 21.06.230 to ensure compliance with AS 21.07.100 - 1613 21.07.180. At least once every two years, the director shall conduct the examinations, 1714 which may include reviewing 1815 (1) prior authorization response times and adherence to specified time 1916 frames; 2017 (2) accuracy and completeness of prior authorization requirements and 2118 restrictions published on the Internet website of the health care insurer; and 2219 (3) consistency of prior authorization practices by all vendors, 2320 utilization review organizations, and third-party contractors. 2421 (c) If a health care insurer does not comply with AS 21.07.100 - 21.07.180, 2522 the director may impose penalties, including a penalty for each instance of 2623 noncompliance, an order to rectify deficiencies within a specified time frame, or, for 2724 persistent or severe violations, suspension or revocation of the health care insurer's 2825 certificate of authority. The director shall impose penalties based on the nature and 2926 severity of the noncompliance, with consideration given to the health care insurer's 3027 history of adherence to the requirements of AS 21.07.100 - 21.07.180 and efforts to 3128 remedy violations. 29 (d) The director shall adopt regulations establishing penalties for 30 noncompliance with AS 21.07.100 - 21.07.180. The civil penalty for a single instance 31 of noncompliance may not exceed $25,000.

01 (d) The director shall adopt regulations establishing penalties for 02 noncompliance with AS 21.07.100 - 21.07.180. The civil penalty for a single instance 03 of noncompliance may not exceed $25,000. 04 * Sec. 3. AS 21.07.250 is amended by adding new paragraphs to read: 0502 (15) "chronic condition" means a medical condition or disease 0603 expected to last at least 12 months or expected to persist over the lifetime of an 0704 individual, requiring ongoing medical care to manage symptoms or prevent 0805 progression; 0906 (16) "covered person" means a policyholder, subscriber, enrollee, or 1007 other individual participating in a health care insurance policy; 1108 (17) "expedited request" means a request by a health care provider for 1209 approval of medical care or a prescription drug when the covered person is undergoing 1310 a current course of treatment using a nonformulary drug or for which the passage of 1411 time 1512 (A) could jeopardize the life or health of the covered person; 1613 (B) could jeopardize the ability of a covered person to regain 1714 maximum function; or 1815 (C) would, as determined by a health care provider with 1916 knowledge of the covered person's medical condition, subject the covered 2017 person to severe pain that cannot be adequately managed without the medical 2118 care or prescription drug that is the subject of the request; 2219 (18) "prior authorization" means the process used by a health care 2320 insurer to determine the medical necessity or medical appropriateness of covered 2421 medical care before the medical care is provided or a requirement that a covered 25 person or health care provider notify a health care insurer before receiving or 26 providing medical care; 2722 (19) "standard request" means a request by a health care provider for 2823 approval of medical care or a prescription drug for which the request is made in 2924 advance of the covered person's obtaining medical care or a prescription drug that is 3025 not required to be expedited; 3126 (20) "step-therapy protocol" means a protocol, policy, or program used 27 by a health care insurer or utilization review organization that establishes which 28 prescription drugs are medically appropriate for a particular covered person and the 29 specific sequence in which the prescription drugs should be administered for a 30 specified medical condition, whether by self-administration or administration by a 31 health care provider, under a pharmacy or medical benefit of a health care insurance

01by a health care insurer or utilization review organization that establishes which 02 prescription drugs are medically appropriate for a particular covered person and the 03 specific sequence in which the prescription drugs should be administered for a 04 specified medical condition, whether by self-administration or administration by a 05 health care provider, under a pharmacy or medical benefit of a health care insurance 0601 plan; 0702 (21) "utilization review organization" means an entity, other than a 0803 health care insurer performing utilization review for the health care insurer's own 0904 health insurance policy, that conducts any part of utilization review. 1005 * Sec. 4. The uncodified law of the State of Alaska is amended by adding a new section to 1106 read: 1207 TRANSITION: REGULATIONS. The director of the division of insurance may adopt 1308 regulations necessary to implement this Act. The regulations take effect under AS 44.62 1409 (Administrative Procedure Act), but not before the effective date of the law implemented by 1510 the regulation. 1611 * Sec. 5. Section 4 of this Act takes effect immediately under AS 01.10.070(c). 1712 * Sec. 6. Except as provided in sec. 5 of this Act, this Act takes effect January 1, 2027.

Welcome to The Alaska State Legislature

26 párrafos sin cambios

This web site is the place to track bills, locate and contact your legislators, and access committee information. Questions? Try our help wizard or call 907-465-4648.

WHO REPRESENTS ME??

Quick Links

Infobases

Districts

FAQ

Legislative Information Offices

Legislative Affairs Agency

Public Opinion Messages

Legislative Links

Finance

Audit

Ombudsman

100 Years Centennial

Office of Victims' Rights

Statutory Reporting

Ethics

LB&A

senate

Majority

Minority

house

Majority

Minority

Disclaimer / Credits

Webmaster

Accessibility

Volver al texto completo